UNSPSC 51284136: Cefotaxime sodium

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 258J72S7TZ. European Medicines Agency schedules Cefotaxime sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13276MIG. Cefotaxime sodium generally arises in the molecular formula C16H16N5NAO7S2. The term 'cefotaxime sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cefotaxime sodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFOTAXIME SODIUM remains US FDA's Preferred Term for this commodity. Cefotaxime sodium bears US NLM identifiers UMLS ID C0700445 and NCI Concept Code C2328. SMILES: CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3CSC(N3)N)SC1)C(=O)[O-].[NA+].

UNSPSC 51284136 Cefotaxime sodium is a Commodity code for a specific injectable antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under this code show minimal alignment with cefotaxime procurement itself. Instead, the opportunities reflect broader pharmaceutical and medical supply acquisition — state health departments and counties sourcing oral antibiotics, naloxone, and drug deactivation systems through piggyback contracts and competitive sealed bids. When state and local buyers do source under antibiotic commodity codes, they typically procure through cooperative purchasing agreements such as MMCAP Infuse, leveraging pre-negotiated pricing and pre-qualified vendors to fill warehouse stock for emergency preparedness, public health response, or institutional healthcare operations. The issuing bodies are state health departments and county health or emergency services divisions.

Recent activity shows Illinois Department of Public Health utilizing the MMCAP Infuse consortium for a pharmaceutical piggyback award (Solicitation 26482DPHPREPDB53392, posted August 28, 2026, due September 11, 2026) to Chartwell Rx LLC for oral antibiotic supply, with a total award of $2,999,999.11 over three years including renewals. Seminole County, Florida posted an IFB (IFB60459723LAS, June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries, though this opportunity diverges from the cefotaxime commodity scope. The geographic footprint visible in recent postings spans at least Florida and Illinois. The mismatch between the cefotaxime commodity code and the actual opportunities posted suggests either inconsistent code tagging by procurement offices or minimal recent demand for cefotaxime specifically under state and local solicitations. Firms pursuing antibiotic supply contracts should monitor MMCAP Infuse and equivalent state cooperative purchasing vehicles rather than relying on direct commodity-specific state and local RFPs or IFBs.